Results 41 to 50 of about 11,862,011 (403)
Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis
Frontiers in Immunology, 2022 Psoriasis is a chronic papulosquamous skin disease with an autoimmune pathogenic traits and strong genetic predisposition. In the past few decades, with the rapid development of molecular biology and cell biology, the inherent pathogenesis of psoriasis ...
Qian Shen +9 more
doaj +1 more source
Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis [PDF]
, 2016 Background Medication nonadherence is known to limit the effectiveness of available therapies; however, little is known specifically about medication adherence in people with psoriasis.
Baker +48 more
core +2 more sources
Dermatology Reports, 2022 Dimethyl fumarate (DMF) was recently approved by the European Medicines Agency for systemic treatment of moderate-to-severe chronic plaque psoriasis. Appropriate management of DMF treatment is required to achieve optimal clinical benefits.
Martina Burlando +6 more
doaj +1 more source
Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician's Experience. [PDF]
, 2020 Goeckerman therapy is a highly effective treatment regimen for moderate-to-severe psoriasis. It involves regular exposure to ultraviolet B radiation and the application of crude coal tar.
Bhutani, Tina +5 more
core
Evaluation of the cutaneous microbiome in psoriasis [PDF]
, 2010 Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder primarily involving skin, with distinctive clinical characteristics.
Alexander Alekseyenko +5 more
core +2 more sources
Frontiers in Immunology, 2023 BackgroundThe rate of seroconversion after COVID-19 vaccination in patients with moderate to severe psoriasis requiring systemic treatment is poorly understood.ObjectivesThe aim of this prospective single-center cohort study performed between May 2020 ...
Georg Christian Lodde +14 more
doaj +1 more source
The Treatment of Psoriasis [PDF]
The American Journal of the Medical Sciences, 1898 n ...
openaire +2 more sources
Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis. [PDF]
, 2018 IntroductionPsoriatic arthritis (PsA) is a chronic, inflammatory arthritis that affects an estimated 30% of patients with psoriasis. PsA is underdiagnosed in primary care and dermatology clinics due to a variety of reasons, including failure of ...
Ahn, Richard +3 more
core +3 more sources
Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Case Reports in Rheumatology, 2012 Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms ...
D. Graceffa +6 more
doaj +1 more source
Dermatology Reports, 2023 Genital psoriasis affects 33-63% patients with psoriasis during the course of disease, usually leading to a severe reduction of patient’s quality of life.
Andrea Cortese +8 more
doaj +1 more source